Premium
Granulomas induced by subcutaneous injection of leuprorelin acetate
Author(s) -
SAKAMOTO Ryoko,
HIGASHI Yuko,
MERA Kentaro,
KANEKURA Takuro,
KANZAKI Tamotsu
Publication year - 2006
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.2006.00008.x
Subject(s) - leuprorelin , medicine , prostate cancer , agonist , hormone , luteinizing hormone , cancer , receptor , gonadotropin releasing hormone
Leuprorelin acetate, a chemotherapeutic agent used to treat prostate cancer, is a synthetic luteinizing hormone‐releasing hormone (LHRH) agonist. We report a 75‐year‐old man who presented with several large subcutaneous nodules at the site of leuprorelin acetate injections for his prostatic cancer. A biopsy of the nodules disclosed epithelioid granulomatous inflammation and resulted in a diagnosis of drug‐induced granulomatous reaction to leuprorelin acetate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom